HOME >> MEDICINE >> NEWS
Study: ER could be front line for stroke prevention

agnosed by electro-cardiogram (EKG) in a six-month period in one of three emergency departments in tertiary-care hospitals: UMHS, St. Joseph Mercy Hospital in Ann Arbor, MI, and University of Cincinnati Hospital.

Working from medical records and a database of EKG records, the researchers identified 78,787 emergency patient visits, and 15,238 EKG results. Of those who had EKGs, 871 had AF, and full records were available for 866 of them. This gave the overall AF incidence rate of 1.1 percent.

Patients who had no previous AF diagnosis, or whose AF involved a heart valve, were not included in an analysis of medication patterns. A total of 478 individual patients with recurrent non-valvular AF, 63 of whom had more than one ER visit in the study period, were identified.

The mean age of the 478 patients was 74.5 years, meaning that many of the patients were at an increased risk of stroke not only from their AF but also from their age. Just over one-quarter of the patients had three high-risk factors for stroke.

Warfarin isn't for everyone, so Scott and his colleagues used strict standard guidelines to determine who was eligible for the drug and who wasn't, including those who had bleeding and liver problems, a history of falls or problems walking, or uncontrolled high blood pressure. A total of 240 patients weren't eligible for warfarin under these guidelines, and even some of the patients who were found to be on warfarin would have been ineligible under the guidelines.

Of the 291 patients who were eligible for warfarin, only 55 percent were on the drug. Another 22 percent were using antiplatelet drugs that can help slow clotting. But 23 percent were getting no stroke-prevention therapy at all. And of those who weren't eligible for warfarin but could take antiplatelet or aspirin therapy, only 34 percent were using any of the drugs.

The study also looked at the results of blood-clotting tests called INRs, to see if patien
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
31-Oct-2002


Page: 1 2 3 4

Related medicine news :

1. Study: Two brain systems regulate how we call for help
2. Study: Eye contact triggers threat signals in autistic childrens brains
3. Study: Young adults can be motivated to eat fruits, veggies
4. Study: Physical activity in middle age cuts risk of early death
5. Study: Brain battles itself over short-term rewards, long-term goals
6. Study: Dementia often undiagnosed in clinical settings
7. Study: Too few doctors ask teens about smoking
8. Study: Low-carb diet more effective than low-fat diet
9. Study: Many men take dietary supplements to prevent prostate cancer
10. Study: Height loss screen ultimately could reduce hip fractures
11. Study: New neurons can get out of spinal cord

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Study could front line for stroke prevention

(Date:10/22/2014)... only 24 hours in a day, that doesn’t seem to be ... their busy schedules for exercise and fitness. Fortunately, one does not ... shape. Here are five ways you can reach your fitness and ... Commute , Consider riding a bike or taking the bus or ... If you must use your car to get to work, start ...
(Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
(Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... The newly updated Worldwide Medical Market Forecasts ... facts, figures and forecasts on the global medical markets. ... categories the Worldwide Medical Market Forecasts to 2019 ... on the worldwide medical market to reveal key insights ... data for 2010-2019, covering each country market individually, allowing ...
Breaking Medicine News(10 mins):Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4
(Date:10/22/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... focused on the development of oral drug delivery ... its Phase IIa clinical trial of ORMD-0801, the ... 1 diabetes. The trial was conducted in ... Food and Drug Administration (FDA) Investigational New Drug ...
(Date:10/22/2014)...   Surefire Medical , Inc., the developer of ... targeted delivery of embolization agents in minimally invasive direct-to-tumor ... John R. Daniels , MD of the University of ... Steven C. Katz , MD of the Roger ... Board (SAB).    "The role of the ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
Cached News: